期刊文献+

清络饮治疗胸腹壁血栓性静脉炎96例 被引量:1

Decoction for Clearing Away Heat in Lung Collateral treatment of Mondor disease 96 cases
下载PDF
导出
摘要 [目的]观察中药治疗胸腹壁血栓性静脉炎的疗效。[方法]对1986年以来诊断明确的胸腹壁血栓性静脉炎86例,口服自拟清脉饮连续3周以上观察。[结果]治愈58例(60.4%),好转31例(32.3%),有效率为92.7%。无效7例(7.3%)(包括2例乳腺癌前期病变)。[结论]清络饮治疗胸腹壁血栓性静脉炎疗效显著,胸腹壁静脉炎是一种血栓变态反应性静脉炎。 [Objective] Observe the effect of the treatment of Mondor disease treatment. [Methods] Since 1986 diagnosis specific Mondor disease 86 cases, Oral Decoction for Clearing Away Heat in Lung Collateral continuous observation for more than three weeks. [Results] Cured 58 cases (60.4%) ,improvement in 31 cases (32.3%) ,has 92.7% efficiency. 7 cases of invalid (7.3%) ( including 2 cases of breast cancer precursor lesions). [ Conclusion ] Decoction for Clearing Away Heat in Lung Collateral efficacy of the treatment of Mondor disease significantly, thoracoabdominal wall phlebitis is an allergic phlebitis thrombosis.
出处 《实用中医内科杂志》 2009年第6期92-93,共2页 Journal of Practical Traditional Chinese Internal Medicine
关键词 胸腹壁血栓性静脉炎 清络饮 临床疗效 mondor disease decoction for clearing away heat in lung collateral clinical efficacy
  • 相关文献

参考文献2

二级参考文献12

共引文献8

同被引文献21

  • 1向琳,彭金兰.抗肿瘤新药——贝伐单抗[J].医药导报,2006,25(10):1087-1088. 被引量:1
  • 2裘雁冰,陆益,吴洪斌,凌云华.贝伐单抗及其联用化疗方案的不良反应[J].药物不良反应杂志,2006,8(6):431-433. 被引量:27
  • 3赵林,周建凤,管梅,宁晓红,白春梅,王毓洲,陈书长.贝伐单抗联合化疗治疗晚期结直肠癌5例[J].临床肿瘤学杂志,2007,12(5):385-387. 被引量:3
  • 4Wedam SB,Low JA.Antiangiogenic and antitumor effects of bevacizumab in patients with inflammatory and locally advanced breast cancer[J].Clin Oncol,2006,24(5):769. 被引量:1
  • 5Dincer M,Altundag K.Angiotensin-converting enzyme inhibitors for bevacizumab-induced hypertension[J].Ann Phamacother,2006,40(12):2278-2279. 被引量:1
  • 6Miller K,Wang M,Gralow J,et al.Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer[J].N Engl J Med,2007,357(26):2666-2676. 被引量:1
  • 7Miles DA.Management of toxicity in patients receiving therapy withBevacizumab[J].Eur J Cancer,2008,6(6):29-39. 被引量:1
  • 8Scappaticc FA,Skillings JR,Holden SN,et al.Arterial thrombo-embolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab[J].Natl Cancer Inst,2007,99(16):1232-1239. 被引量:1
  • 9Eremina V,Baelde HJ,Quggin SE.Role 0f the VEGF-a signaling pathway in glomerulus:evidence for crosstalk between components of the glomerular filtration barrier[J].Nephron Physiol,2007,106(2):32-37. 被引量:1
  • 10Hurwitz H,Saini S.Bevacizumab in the treatment of metastatic colo-rectal:safety profile and managerment of advense events[J].Semin Oncol,2006,33(5):S26-S34. 被引量:1

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部